![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 17511-17519, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Mannose-binding lectin (MBL) plays a
critical role in innate immunity. Point mutations in the collagen-like
domain (R32C, G34D, or G37E) of MBL cause a serum deficiency,
predisposing patients to infections and diseases such as rheumatoid
arthritis. We examined whether MBL mutants show enhanced susceptibility
to proteolysis by matrix metalloproteinases (MMPs), which are important
mediators in inflammatory tissue destruction. Human and rat MBL were
resistant to proteolysis in the native state but were cleaved
selectively within the collagen-like domain by multiple MMPs after heat
denaturation. In contrast, rat MBL with mutations homologous to those
of the human variants (R23C, G25D, or G28E) was cleaved
efficiently without denaturation in the collagen-like domain by MMP-2
and MMP-9 (gelatinases A and B) and MMP-14 (membrane type-1 MMP), as
well as by MMP-1 (collagenase-1), MMP-8 (neutrophil collagenase), MMP-3
(stromelysin-1), neutrophil elastase, and bacterial collagenase. Sites
and order of cleavage of the rat MBL mutants for MMP-2 and MMP-9 were:
Gly45-Lys46
Mannose-binding Lectin (MBL) Mutants Are Susceptible to Matrix
Metalloproteinase Proteolysis
POTENTIAL ROLE IN HUMAN MBL DEFICIENCY*
§¶,
,
,
**, and
¶
Oral Biological and Medical
Sciences,
Biochemistry and Molecular Biology, and
** Pathology, University of British Columbia,
Vancouver, British Columbia V6T 1Z3, Canada
Gly51-Ser52
Gly63-Gln64
Asn80-Met81 which differed from that of MMP-14,
Gly39-Leu40
Asn80-Met81, revealing that the MMPs were not
functionally interchangeable. These sites were homologous to those
cleaved in denatured human MBL. Hence, perturbation of the
collagen-like structure of MBL by natural mutations or by denaturation
renders MBL susceptible to MMP cleavage. MMPs are likely to contribute
to MBL deficiency in individuals with variant alleles and may also be
involved in clearance of MBL and modulation of the host response in
normal individuals.
*
This work was supported in part by grants from the Canadian
Institute of Health Research (to C. M. O. and D. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

Holder of Canada Research Chair in Metalloproteinase Biology.
This article has been cited by other articles:
![]() |
G. S. Butler, R. A. Dean, E. M. Tam, and C. M. Overall Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding Mol. Cell. Biol., August 1, 2008; 28(15): 4896 - 4914. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kuhn, A. Coutsoudis, D. Trabattoni, D. Archary, T. Rossi, L. Segat, M. Clerici, and S. Crovella Synergy between mannose-binding lectin gene polymorphisms and supplementation with vitamin A influences susceptibility to HIV infection in infants born to HIV-positive mothers. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 610 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Davies, M.W. Turner, N. Klein, and and the London MBL CF Study Group The London MBL C Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles Eur. Respir. J., November 1, 2004; 24(5): 798 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Larsen, H. O. Madsen, R. B. Sim, C. Koch, and P. Garred Disease-associated Mutations in Human Mannose-binding Lectin Compromise Oligomerization and Activity of the Final Protein J. Biol. Chem., May 14, 2004; 279(20): 21302 - 21311. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Butler, E. M. Tam, and C. M. Overall The Canonical Methionine 392 of Matrix Metalloproteinase 2 (Gelatinase A) Is Not Required for Catalytic Efficiency or Structural Integrity: PROBING THE ROLE OF THE METHIONINE-TURN IN THE METZINCIN METALLOPROTEASE SUPERFAMILY J. Biol. Chem., April 9, 2004; 279(15): 15615 - 15620. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. McQuibban, J.-H. Gong, J. P. Wong, J. L. Wallace, I. Clark-Lewis, and C. M. Overall Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood, July 30, 2002; 100(4): 1160 - 1167. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |